(Q45360289)

English

Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma.

scientific article published on 8 March 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261816%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261816%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Epstein–Barr virus

0 references

Jaap M Middeldorp

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261816%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261816%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

K F Hui

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261816%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Dona N Ho

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261816%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

C M Tsang

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261816%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

George S W Tsao

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261816%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

0 references

publication date

8 March 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261816%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261816%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

131

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261816%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261816%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1930-1940

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261816%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27439

21 January 2018

The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disorders

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27439

21 January 2018

Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27439

21 January 2018

Valproic acid enhances the efficacy of chemotherapy in EBV-positive tumors by increasing lytic viral gene expression

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27439

21 January 2018

Use of adenovirus vectors expressing Epstein-Barr virus (EBV) immediate-early protein BZLF1 or BRLF1 to treat EBV-positive tumors.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27439

21 January 2018

Inhibition of nasopharyngeal carcinoma growth by RTA-expressing baculovirus vectors containing oriP.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27439

21 January 2018

Activators of the Epstein-Barr virus lytic program concomitantly induce apoptosis, but lytic gene expression protects from cell death

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27439

21 January 2018

Inhibition of p38 MAP kinase pathway induces apoptosis and prevents Epstein Barr virus reactivation in Raji cells exposed to lytic cycle inducing compounds.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27439

21 January 2018

Establishment of a cell line (NPC/HK1) from a differentiated squamous carcinoma of the nasopharynx.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27439

21 January 2018

Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27439

21 January 2018

Recurrent chemical reactivations of EBV promotes genome instability and enhances tumor progression of nasopharyngeal carcinoma cells.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27439

21 January 2018

STAT3 activation contributes directly to Epstein-Barr virus-mediated invasiveness of nasopharyngeal cancer cells in vitro.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27439

21 January 2018

Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27439

21 January 2018

Reactivation of Epstein-Barr virus from latency

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27439

21 January 2018

Epstein-Barr virus and cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27439

21 January 2018

Epstein-Barr virus BART gene expression.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27439

21 January 2018

Qualitative analysis of the expression of Epstein-Barr virus lytic genes in nasopharyngeal carcinoma biopsies

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27439

21 January 2018

Virally targeted therapies for EBV-associated malignancies

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27439

21 January 2018

Lytic induction and apoptosis of Epstein-Barr virus-associated gastric cancer cell line with epigenetic modifiers and ganciclovir

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27439

21 January 2018

The Epstein-Barr virus immediate-early protein BZLF1 regulates p53 function through multiple mechanisms

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27439

21 January 2018

The Epstein-Barr virus immediate-early protein BZLF1 induces both a G(2) and a mitotic block

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27439

21 January 2018

Epstein-Barr virus (EBV) Rta-mediated EBV and Kaposi's sarcoma-associated herpesvirus lytic reactivations in 293 cells.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27439

21 January 2018

The DNase of gammaherpesviruses impairs recognition by virus-specific CD8+ T cells through an additional host shutoff function

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27439

21 January 2018

Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27439

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45360289&oldid=1237334489"